Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.14050 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Signe Kjeldgaard Jensen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Department of Pediatrics, Herlev and Gentofte Hospital, University of Copenhagen, Cop…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Lundbeck Foundation, Ministry of Health, Danish Council for Strategic Research.
Abstract (Originalsprache)
Background
Blood eosinophil count is a well‐established biomarker of atopic diseases in older children and adults. However, its predictive role for atopic diseases in preschool children is not well established.
Objective
To investigate the association between blood eosinophil count in children and development of atopic diseases up to age 6 years.
Methods
We investigated blood eosinophil count at age 18 months and 6 years in relation to recurrent wheeze/asthma, atopic dermatitis, allergic rhinitis, and allergic sensitization during the first 6 years of life in the two Copenhagen Prospective Studies on Asthma in Childhood cohorts ( n = 1111). Blood eosinophil count was investigated in association with remission of existing atopic disease, current atopic disease, and later development of atopic disease.
Results
Blood eosinophil count at 18 months was not associated with current wheezing/asthma or atopic dermatitis, while blood eosinophil count at age 6 years was associated with increased occurrence of current wheezing/asthma (OR = 1.1; 1.04–1.16, p = .0005), atopic dermatitis (OR = 1.06; 1.01–1.1, p = .02), and allergic rhinitis (OR = 1.11; 1.05–1.18, p = .0002). Blood eosinophil count at 18 months did not predict persistence or development of recurrent wheeze/asthma or atopic dermatitis at age 6 years.
Conclusion
Blood eosinophil count at 18 months was not associated with current wheezing/asthma or atopic dermatitis and did not predict persistence or development of disease. This implies a limited clinical role of blood eosinophil levels in early‐life atopic disease and questions the clinical value of blood eosinophil counts measured in toddlers as a predictive biomarker for subsequent atopic disease in early childhood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Department of Pediatrics, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Pediatrics, Slagelse Hospital, Slagelse, Denmark.
- Section of Microbiology and Fermentation, Department of Food Science, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Signe Kjeldgaard Jensen, Mathias Elsner Melgaard, Casper-Emil Tingskov Pedersen, Luo Yang, Nilo Vahman, Jacob P Thyssen, Ann-Marie M Schoos, Jakob Stokholm, Hans Bisgaard, Bo Chawes, Klaus Bønnelykke
Förderung
- Lundbeck Foundation
- Ministry of Health
- Danish Council for Strategic Research
- China Scholarship Council
- Lundbeckfonden
- Strategiske Forskningsråd
Zitieren
APA
Jensen, S. K., Melgaard, M. E., Pedersen, C. T., Yang, L., Vahman, N., Thyssen, J. P., Schoos, A. M., Stokholm, J., Bisgaard, H., Chawes, B., & Bønnelykke, K. (2023). Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14050
Vancouver
Jensen SK, Melgaard ME, Pedersen CT, Yang L, Vahman N, Thyssen JP, et al. Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.14050
BibTeX
@article{Jensen2023,
author = {Jensen, Signe Kjeldgaard and Melgaard, Mathias Elsner and Pedersen, Casper-Emil Tingskov and Yang, Luo and Vahman, Nilo and Thyssen, Jacob P and Schoos, Ann-Marie M and Stokholm, Jakob and Bisgaard, Hans and Chawes, Bo and Bønnelykke, Klaus},
title = {Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.14050}
}
EUVIMED